( OTC-BB:ONCS )

News from OncoSec Medical Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

13 May, 2014, 06:03 ET OncoSec Medical To Present At The Third Annual Marcum MicroCap Conference

 OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, announced today that...


15 Aug, 2013, 08:35 ET Excitement Builds as Electrical Pulses Prove Potent Against Advanced Skin Cancers

 We have come a long way in the use of electricity. In ancient Greece, Thales of Miletus discovered he could produce electrical sparks by...


18 Mar, 2013, 06:09 ET OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


14 Mar, 2013, 06:07 ET OncoSec Medical to Present at the 25th Annual Roth Conference

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


26 Feb, 2013, 06:14 ET OncoSec Medical Announces Formation of Melanoma Advisory Board

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


19 Feb, 2013, 06:07 ET OncoSec Medical Promotes Veronica Vallejo to Chief Financial Officer

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


03 Jan, 2013, 06:08 ET OncoSec Medical to Present at Biotech Showcase(TM) 2013 in San Francisco on January 8

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


15 Nov, 2012, 06:02 ET OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


14 Nov, 2012, 06:06 ET OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


09 Oct, 2012, 06:08 ET OncoSec Medical to Present Data at Two Upcoming Conferences

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to...


25 Sep, 2012, 06:12 ET OncoSec Establishes Clinical Site for Its Phase II Metastatic Melanoma Trial at University of Washington

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...


20 Sep, 2012, 06:07 ET OncoSec to Present at Upcoming Healthcare and Investor Conferences

  OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy...


11 Sep, 2012, 06:06 ET OncoSec Secures License for Electroporation Intellectual Property from University of South Florida

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse and NeoPulse therapies to treat solid tumor cancers,...


29 Aug, 2012, 06:08 ET OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its ImmunoPulse and NeoPulse therapies to treat solid tumor cancers, announced it will be...


30 Jul, 2012, 06:09 ET OncoSec Receives ISO 13485 Quality Management System Certification

 OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers,...


24 Jul, 2012, 06:08 ET OncoSec Featured on KTVU-TV News and in San Francisco Chronicle

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers, was...


23 Jul, 2012, 06:07 ET OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies

 OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat...


26 Jun, 2012, 06:09 ET OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012

OncoSec Medical Inc. (OTCBB:ONCS), a company developing the OncoSec Medical System (OMS) ElectroOncology therapies to treat advanced-stage solid...


19 Jun, 2012, 06:08 ET OncoSec Announces Issuance of New Patent for Method of Use

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing the OncoSec Medical System (OMS) ElectroOncology therapies to treat advanced-stage...


10 May, 2012, 06:01 ET OncoSec to Present at Upcoming Investor Conference

OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...


10 Apr, 2012, 06:01 ET OncoSec Executive Team Contributes to Manufacturing Chemist and Company Profile Featured in San Diego Business Journal

 OncoSec Medical Inc. (OTCBB: ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat...


24 Feb, 2012, 06:01 ET OncoSec to Present at 10th Annual BioPartnering North America

 OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat...


08 Feb, 2012, 06:01 ET OncoSec To Present at BIO CEO & Investor Conference

OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...


24 Jan, 2012, 06:01 ET OncoSec to Present at World Cancer Immunotherapy Conference

 OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat...


17 Jan, 2012, 06:01 ET OncoSec Medical President and CEO Contributes to Drug Discovery News

 OncoSec Medical Incorporated (OTCBB:ONCS), which is developing its advanced-stage Oncology Medical System (OMS) ElectroOncology therapies to...